​
​

Imunon Ownership 2024 | Who Owns Imunon Now?

OverviewRevenueFinancialsChartTranscripts

Insider Ownership

1.10%

Imunon Insider Shareholders Trades

Open Market Insider Trades

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Aug 16, 2024Lindborg Stacydirector, officer President and CEOP-PurchaseBuy25,000$0.98$24.50K264,166
Aug 16, 2024Tardugno Michael Hdirector, officer Executive Chairman of BoardP-PurchaseBuy25,000$1.03$25.75K353,346

Open Market Insider Buys

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Aug 16, 2024Lindborg Stacydirector, officer President and CEOP-PurchaseBuy25,000$0.98$24.50K264,166
Aug 16, 2024Tardugno Michael Hdirector, officer Executive Chairman of BoardP-PurchaseBuy25,000$1.03$25.75K353,346

Insider Sells

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Jun 10, 2024Gaiero David Gofficer Chief Financial OfficerSell----

All Insider Owners Trades

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Aug 16, 2024Lindborg Stacydirector, officer President and CEOP-PurchaseBuy25,000$0.98$24.50K264,166
Aug 16, 2024Tardugno Michael Hdirector, officer Executive Chairman of BoardP-PurchaseBuy25,000$1.03$25.75K353,346
Jun 14, 2024Tardugno Michael Hdirector, officer Executive Chairman of BoardA-AwardBuy100,000$1.22$122.00K328,346
Jun 14, 2024Lindborg Stacydirector, officer President and CEOA-AwardBuy112,500$1.22$137.25K239,166
Jun 14, 2024Anwer Khursheedofficer Chief Scientific OfficerA-AwardBuy25,000$1.22$30.50K135,688
Jun 14, 2024Fritz Frederick J.director-A-AwardBuy3,500$1.22$4.27K37,099
Jun 14, 2024Pellizzari Christine Adirector-A-AwardBuy4,500$1.22$5.49K18,666
Jun 14, 2024Dentzer James Edirector-A-AwardBuy4,500$1.22$5.49K13,667
Jun 14, 2024Braun Donald Pdirector-A-AwardBuy3,500$1.22$4.27K23,430
Jun 10, 2024Gaiero David Gofficer Chief Financial OfficerSell----
May 14, 2024Lindborg Stacydirector, officer President and CEOA-AwardBuy112,500$1.48$166.50K126,666
Mar 18, 2024CHURCH JEFFREY WAYNEofficer CFOA-AwardBuy25,000$0.86$21.50K120,950
Mar 18, 2024Anwer Khursheedofficer Chief Scientific OfficerA-AwardBuy25,000$0.86$21.50K110,688
Mar 18, 2024Tardugno Michael Hdirector, officer Executive Chairman of BoardA-AwardBuy12,500$0.86$10.75K228,346
Mar 18, 2024Fritz Frederick J.director-A-AwardBuy3,500$0.86$3.01K33,599
Mar 18, 2024Braun Donald Pdirector-A-AwardBuy3,500$0.86$3.01K19,930
Mar 18, 2024Pellizzari Christine Adirector-A-AwardBuy4,500$0.86$3.87K14,166
Mar 18, 2024Lindborg Stacydirector-A-AwardBuy4,500$0.86$3.87K14,166
Mar 18, 2024Dentzer James Edirector-A-AwardBuy4,500$0.86$3.87K9,167
Dec 11, 2023Hazard Sebastienofficer Chief Medical OfficerA-AwardBuy80,000$0.88$70.40K80,000

The last insider sell of Imunon's stock was made by Gaiero David G on Jun 10 2024, selling - shares at - per share (valued at -). The last insider buy of IMNN was made by Lindborg Stacy on Aug 16 2024, buying 25,000 shares at $0.98 per share (worth $24.50K).

Imunon Insider Ownership Trends

All Insider Trades Trend

DateBuySellBuy/Sell Ratio
Q3 20242--
Q2 202481800.00%
Q1 20248--
Q4 202321200.00%
Q1 202310--
Q3 202243133.33%
Q2 202220--
Q1 202216--
Q4 202141400.00%
Q2 202143133.33%
Q1 202114--
Q2 20203414242.86%
Q1 202018--
Q4 201922--
Q3 20196--
Q2 201922--
Q1 201921--
Q4 20186--
Q3 20188--
Q2 201823--

2 total buy trades, and 0 total sell trades (buy/sell ratio of 0%) were made by Imunon's insiders, as of Q3 2024.

Open Market Insider Trades Trend

DateBuySellBuy/Sell Ratio
Q3 20242--
Q2 2024---
Q1 2024---
Q4 2023---
Q1 2023---
Q3 2022---
Q2 20224--
Q1 20222--
Q4 20212--
Q2 20211--
Q1 2021---
Q2 2020---
Q1 20202--
Q4 20196--
Q3 20196--
Q2 20196--
Q1 20194--
Q4 20186--
Q3 20188--
Q2 20182--

As of Q3 2024, Insider owners conducted 2 open market buy trades and 0 open market sell trades of Imunon's stocks.

Imunon Peer Ownership

TickerCompany
SNTISenti Biosciences, Inc.
BLCMBellicum Pharmaceuticals, Inc.
CYCCCyclacel Pharmaceuticals, Inc.
XCURExicure, Inc.
HSTOHistogen Inc.
SABSSAB Biotherapeutics, Inc.
LSTALisata Therapeutics, Inc.
LIXTLixte Biotechnology Holdings, Inc.
TOVXTheriva Biologics, Inc.
QNRXQuoin Pharmaceuticals, Ltd.
DFFNCervoMed Inc.
HILSTharimmune, Inc.
CINGCingulate Inc.
KAKineta, Inc.
AVTXAvalo Therapeutics, Inc.
DMACDiaMedica Therapeutics Inc.
NLTXNeurogene Inc.
CBIOGyre Therapeutics, Inc.
LUMOLumos Pharma, Inc.

IMNN Ownership FAQ